- Home
- BFRG vs RNAZ Comparison
BFRG vs RNAZ Comparison
Compare BFRG & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BFRG | RNAZ |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | United States | United States |
| Employees | 17 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9M | 5.6M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | BFRG | RNAZ |
|---|---|---|
| Price | $0.79 | $5.34 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 295.8K | 9.8K |
| Earning Date | 05-12-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.43 | $5.01 |
| 52 Week High | $2.04 | $20.99 |
Technical Indicators
Market Signals| Indicator | BFRG | RNAZ |
|---|---|---|
| Relative Strength Index (RSI) | 56.39 | 22.60 |
| Support Level | $0.65 | N/A |
| Resistance Level | $0.82 | $9.37 |
| Average True Range (ATR) | 0.06 | 0.65 |
| MACD | 0.02 | -0.10 |
| Stochastic Oscillator | 85.89 | 13.16 |
Price Performance
Historical ComparisonAbout BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.